Free Trial

Werewolf Therapeutics (HOWL) Competitors

Werewolf Therapeutics logo
$1.07 +0.02 (+1.90%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$1.06 -0.01 (-0.47%)
As of 07/2/2025 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HOWL vs. DSGN, ESPR, NBTX, MDWD, CRDF, IMAB, PRQR, SOPH, SCPH, and MNPR

Should you be buying Werewolf Therapeutics stock or one of its competitors? The main competitors of Werewolf Therapeutics include Design Therapeutics (DSGN), Esperion Therapeutics (ESPR), Nanobiotix (NBTX), MediWound (MDWD), Cardiff Oncology (CRDF), I-Mab (IMAB), ProQR Therapeutics (PRQR), SOPHiA GENETICS (SOPH), scPharmaceuticals (SCPH), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical products" industry.

Werewolf Therapeutics vs. Its Competitors

Design Therapeutics (NASDAQ:DSGN) and Werewolf Therapeutics (NASDAQ:HOWL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

56.6% of Design Therapeutics shares are held by institutional investors. Comparatively, 64.8% of Werewolf Therapeutics shares are held by institutional investors. 31.2% of Design Therapeutics shares are held by company insiders. Comparatively, 23.6% of Werewolf Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Design Therapeutics' average media sentiment score of 1.89 equaled Werewolf Therapeutics'average media sentiment score.

Company Overall Sentiment
Design Therapeutics Very Positive
Werewolf Therapeutics Very Positive

Design Therapeutics has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Comparatively, Werewolf Therapeutics has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.

Design Therapeutics currently has a consensus target price of $4.00, suggesting a potential upside of 8.70%. Werewolf Therapeutics has a consensus target price of $8.33, suggesting a potential upside of 678.82%. Given Werewolf Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Werewolf Therapeutics is more favorable than Design Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Design Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Werewolf Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Design Therapeutics has higher earnings, but lower revenue than Werewolf Therapeutics. Design Therapeutics is trading at a lower price-to-earnings ratio than Werewolf Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Design TherapeuticsN/AN/A-$49.59M-$0.99-3.72
Werewolf Therapeutics$1.88M25.54-$70.51M-$1.67-0.64

Design Therapeutics' return on equity of -22.85% beat Werewolf Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Design TherapeuticsN/A -22.85% -22.02%
Werewolf Therapeutics N/A -89.37%-54.87%

Summary

Design Therapeutics and Werewolf Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.

Get Werewolf Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HOWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HOWL vs. The Competition

MetricWerewolf TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$47.12M$2.88B$5.54B$8.87B
Dividend YieldN/A2.64%5.39%4.10%
P/E Ratio-0.6421.3126.1619.90
Price / Sales25.54278.47413.33113.66
Price / CashN/A41.4736.1356.90
Price / Book0.657.518.055.38
Net Income-$70.51M-$55.05M$3.15B$248.50M
7 Day Performance-6.14%2.07%1.43%2.04%
1 Month Performance-21.32%4.84%3.62%4.84%
1 Year Performance-50.00%5.37%34.92%20.23%

Werewolf Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOWL
Werewolf Therapeutics
3.7259 of 5 stars
$1.07
+1.9%
$8.33
+678.8%
-48.1%$47.12M$1.88M-0.6440Positive News
DSGN
Design Therapeutics
0.7394 of 5 stars
$3.90
+4.3%
$4.00
+2.6%
+15.0%$212.32MN/A-3.9440
ESPR
Esperion Therapeutics
4.1737 of 5 stars
$1.04
-2.8%
$7.00
+573.1%
-50.9%$212.07M$332.31M-1.30200
NBTX
Nanobiotix
2.4603 of 5 stars
$4.45
-0.5%
$8.00
+79.8%
-7.1%$210.68M-$11.61M0.00100Gap Down
MDWD
MediWound
1.8364 of 5 stars
$18.99
-0.5%
$31.80
+67.5%
+22.9%$206.32M$20.22M-9.0980News Coverage
CRDF
Cardiff Oncology
1.6866 of 5 stars
$3.16
+1.9%
$12.00
+279.7%
+72.6%$206.23M$680K-3.4320
IMAB
I-Mab
3.0741 of 5 stars
$2.46
-1.6%
$5.50
+123.6%
+44.9%$204.15M$3.89M0.00380News Coverage
PRQR
ProQR Therapeutics
2.1302 of 5 stars
$1.95
+1.0%
$8.00
+310.3%
+29.5%$203.06M$20.46M-5.57180News Coverage
SOPH
SOPHiA GENETICS
2.834 of 5 stars
$3.05
+0.3%
$6.80
+123.0%
-33.8%$202.73M$65.17M-3.05520Positive News
SCPH
scPharmaceuticals
4.6169 of 5 stars
$3.83
-0.3%
$14.00
+265.5%
-4.0%$202.72M$36.33M-2.0130
MNPR
Monopar Therapeutics
3.03 of 5 stars
$31.83
-3.1%
$56.50
+77.5%
+876.7%$200.95MN/A-9.1510Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:HOWL) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners